Literature DB >> 12537262

Rheumatological management of patients with hemophilia. Part II: Muscle hematomas and pseudotumors.

Michel Alcalay1, Adeline Deplas.   

Abstract

Although less common than hemarthroses, muscle hematomas nearly always threaten limb function and can threaten life. Their treatment is not as well standardized as that of hemarthrosis but also rests on clotting factor replacement, prevention of contractures, and rehabilitation. Pseudotumors raise even greater treatment challenges and usually require surgery in adults. Presence of an inhibitor is no longer a contraindication to surgery. In HIV-infected patients, surgery is possible only if the CD4+ count is sufficiently high.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12537262     DOI: 10.1016/s1297-319x(02)00451-7

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  3 in total

1.  Thigh pain in a 73-year-old man.

Authors:  Tonya L Dixon; Mark J Kransdorf; Murli Krishna; Mary I O'Connor
Journal:  Clin Orthop Relat Res       Date:  2009-01-29       Impact factor: 4.176

2.  Hematoma Resolution In Vivo Is Directed by Activating Transcription Factor 1.

Authors:  Anusha Seneviratne; Yumeng Han; Eunice Wong; Edward R H Walter; Lijun Jiang; Luke Cave; Nicholas J Long; David Carling; Justin C Mason; Dorian O Haskard; Joseph J Boyle
Journal:  Circ Res       Date:  2020-07-01       Impact factor: 17.367

3.  Nonhemophiliac musculoskeletal pseudotumor.

Authors:  Indrani Sen; Dheepak Selvaraj; Prabhu Premkumar; Sunil Agarwal
Journal:  J Vasc Surg Cases       Date:  2015-06-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.